Background: Cholecystectomy, whether performed laparoscopically or via open approach, triggers a systemic inflammatory response characterized by elevated proinflammatory cytokines. Beetroot (Beta vulgaris) contains bioactive compounds including betalains, dietary nitrates, and polyphenols with demonstrated anti-inflammatory and antioxidant properties. This article evaluates the potential of beetroot as a natural anti-inflammatory agent in post-cholecystectomy recovery. Methods: A systematic literature search was conducted following PRISMA 2020 guidelines across PubMed, Google Scholar, and SciSpace databases. Inclusion criteria encompassed RCT and quasi-experimental studies investigating beetroot or its bioactive constituents in cholecystectomy, abdominal surgery, or relevant models of systemic inflammation. Studies were assessed for effects on inflammatory markers (C-reactive protein, interleukin-6, tumor necrosis factor-alpha) and clinical outcomes. Results No direct clinical trials of beetroot supplementation in cholecystectomy patients were identified. Evidence from related contexts demonstrated that beetroot juice supplementation reduced IL-6, TNF-alpha, and NF-κB in patients with type 2 diabetes. Animal models showed betalain-enriched extracts attenuated oxidative stress and inflammation in surgical wound healing and ischemia-reperfusion injury models.. Conclusion: While mechanistic and preclinical evidence supports the anti-inflammatory potential of beetroot constituents, direct clinical evidence in cholecystectomy patients is absent. Future perioperative trials are warranted to establish efficacy, optimal dosing, timing, and safety profiles.
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.